Endoscopic retrograde cholangiopancreatography (ERCP) is an invasive endoscopic technique that has many diagnostic and therapeutic implications. It is a procedure with small but significant life-threatening complications. To ensure the best possible care, minimize complications, and improve the quality of health care, a constant review of the performance of the operator using ideal benchmark standards is needed. Hence, quality indicators are necessary. The American and European Societies of Gastrointestinal Endoscopy have provided guidelines on quality measures for ERCP, which describe the skills to be developed and training to be implemented in performing quality ERCP. These guidelines have divided the indicators into pre-procedure, intraprocedural, and post-procedure measures. The focus of this article was to review the quality indicators of ERCP.
Citations
Citations to this article as recorded by
Endoscopic retrograde cholangiopancreatography training using a silicone simulator fabricated using a 3D printing technique (with videos) Suk Pyo Shin, Kyong Joo Lee, Min Je Sung, Jong Chan Kim, Guk Bae Kim, Moo Yeop Kim, Sung Yong Han, Sung Ill Jang, Mamoru Takenaka, Chang-Il Kwon Scientific Reports.2025;[Epub] CrossRef
Advancements in Research on Challenges in Selective Biliary Cannulation during Endoscopic Retrograde Cholangiopancreatography (ERCP) 天雨 张 Journal of Clinical Personalized Medicine.2024; 03(01): 100. CrossRef
Development of an Automated Endoscopic Retrograde Cholangiopancreatography Quality Report Card Using an Integrated Analytics Suite Anmol Singh, Eric Swei, Celestina Tolosa, Matthew Alverson, Todd A. Brenner, Avleen Kaur, Aida Metri, Mohammed Rifat Shaik, Nikhil Bush, Branislav Bujnak, Alexandra T. Strauss, Mouen Khashab, Eun Ji Shin, Vikesh K. Singh, Venkata S. Akshintala Techniques and Innovations in Gastrointestinal Endoscopy.2024; 26(3): 230. CrossRef
Endoscopic retrograde cholangiopancreatography training conditions, results from a pan‐European survey: Between vision and reality Karim Hamesch, Oscar Cahyadi, Stavros Dimitriadis, Marcus Hollenbach, Pilar Acedo, Myriam Ayari, Helena Dauvarte, Egle Dieninyte, Viktor Domislovic, Ana Dugic, Martin Ďuriček, Omar Elshaarawy, Anne Fennessy, Mark Enrik Geissler, Zornitsa Gorcheva, Amer Ha United European Gastroenterology Journal.2024;[Epub] CrossRef
Validity of a virtual reality endoscopic retrograde cholangiopancreatography simulator: can it distinguish experts from novices? Konstantinos Georgiou, Nikola Boyanov, Pantelis Antonakis, Dimitrios Thanasas, Gabriel Sandblom, Lars Enochsson Frontiers in Surgery.2023;[Epub] CrossRef
Esophagogastroduodenoscopy (EGD) has been used to diagnose a wide variety of upper gastrointestinal diseases. In particular, EGD is used to screen high-risk subjects of gastric cancer. Quality control of EGD is important because the diagnostic rate is examiner-dependent. However, there is still no representative quality indicator that can be uniformly applied in EGD. There has been growing awareness of the importance of quality control in improving EGD performance. Therefore, we aimed to review the available and emerging quality indicators for diagnostic EGD.
Citations
Citations to this article as recorded by
Endoscopic Submucosal Dissection of Gastric High-Grade Foveolar Dysplasia With Normal Background Mucosa Gonzalo Latorre, Alberto Espino, Christine E. Orr, Robert Bechara Gastro Hep Advances.2025; 4(2): 100565. CrossRef
GastroHUN an Endoscopy Dataset of Complete Systematic Screening Protocol for the Stomach Diego Bravo, Juan Frias, Felipe Vera, Juan Trejos, Carlos Martínez, Martín Gómez, Fabio González, Eduardo Romero Scientific Data.2025;[Epub] CrossRef
Current status of quality control in screening esophagogastroduodenoscopy and the emerging role of artificial intelligence Lihui Zhang, Liwen Yao, Zihua Lu, Honggang Yu Digestive Endoscopy.2024; 36(1): 5. CrossRef
Simethicone and N-acetyl cysteine in improving mucosal visibility: Towards a “clearer view” during endoscopy Akash Roy, Mahesh K. Goenka Indian Journal of Gastroenterology.2024; 43(5): 863. CrossRef
Relationship between observation time and detection rate of focal lesions in Esophagogastroduodenoscopy: a single-center, retrospective study Li Dong, Xiaodan Zhang, Yuting Xuan, Peiling Xiong, Yumei Ning, Bing Zhang, Fan Wang, Qiu Zhao, Jun Fang BMC Gastroenterology.2024;[Epub] CrossRef
The Effect of Esophagogastroduodenoscopy on Intraocular Pressure Maddalena De Bernardo, Antonella Santonicola, Marco Gioia, Livio Vitiello, Ferdinando Cione, Sergio Pagliarulo, Paola Iovino, Nicola Rosa Journal of Clinical Medicine.2024; 13(5): 1224. CrossRef
The Diagnostic Performance of Linked Color Imaging Compared to White Light Imaging in Endoscopic Diagnosis of Helicobacter pylori Infection: A Systematic Review and Meta-Analysis Jae Gon Lee, In Kyung Yoo, Abdullah Ozgur Yeniova, Sang Pyo Lee Gut and Liver.2024; 18(3): 444. CrossRef
Optimal number of images and 2-year interval affect cancer detection in screening esophagogastroduodenoscopy: An observational study Kazuhiro Ksahiwagi, Toshifumi Yoshida, Kayoko Fukuhara, Rieko Bessho, Hitoshi Ichikawa, Nagamu Inoue, Hiromasa Takaishi, Yasushi Iwao, Takanori Kanai Medicine.2024; 103(26): e38774. CrossRef
Sistema de auditoría automática para la exploración endoscópica del estómago con Inteligencia Artificial – Gastro UNAL: Gastroendoscopy UNit for Automatic Labeling Martín Alonso Gómez Zuleta, Diego Fernando Bravo Higuera, Josué Andre Ruano Balseca, María Jaramillo González, Fabio Augusto González Osorio, Edgar Eduardo Romero Castro Revista colombiana de Gastroenterología.2024; 39(2): 133. CrossRef
Optimal Surveillance of Metachronous Gastric Lesion after Endoscopic Resection of Early Gastric Cancer Dong Chan Joo, Gwang Ha Kim Gut and Liver.2024; 18(5): 781. CrossRef
Chronic Atrophic Gastritis and Intestinal Metaplasia: A Latin American Perspective Arnoldo Riquelme, Felipe Silva, Diego Reyes, Gonzalo Latorre The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2024; 24(3): 218. CrossRef
Esophagogastroduodenoscopy Quality Improvement and the Role of Topical Antiperistaltic Agents: A Systematic Review and Meta-Analysis Eoghan Burke, Patricia Harkins, Mayilone Arumugasamy Cureus.2024;[Epub] CrossRef
Endoscopic Imaging for the Diagnosis of Neoplastic and Pre-Neoplastic Conditions of the Stomach Bruno Costa Martins, Renata Nobre Moura, Angelo So Taa Kum, Carolina Ogawa Matsubayashi, Sergio Barbosa Marques, Adriana Vaz Safatle-Ribeiro Cancers.2023; 15(9): 2445. CrossRef
The effect of short-term training about depth predicting score on the diagnostic ability of invasion depth for differentiated early gastric Cancer among non-expert endoscopists Hui Li, Hui Hu, Ping Geng, Panhui Guo, Yuanrong Zhu, Lulu Zeng, Jun Liu, Xiangpeng Hu BMC Medical Education.2023;[Epub] CrossRef
Variation in the rate of detection of minute and small early gastric cancers at diagnostic endoscopy may reflect the performance of individual endoscopists Daisuke Murakami, Masayuki Yamato, Yuji Amano, Takayoshi Nishino, Makoto Arai BMJ Open Gastroenterology.2023; 10(1): e001143. CrossRef
Improving the quality of the esophagogastroduodenoscopy in Helicobacter pylori-naïve gastric cancer Jae Myung Park Clinical Endoscopy.2023; 56(4): 453. CrossRef
Enhancing the Quality of Upper Gastrointestinal Endoscopy: Current Indicators and Future Trends Caesar Ferrari, Micheal Tadros Gastroenterology Insights.2023; 15(1): 1. CrossRef
Antispasmodic Agent Administration Improves Gastric Neoplasm Detection Rates during Esophagogastroduodenoscopy Sang Yoon Kim, Jae Myung Park The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2022; 22(3): 246. CrossRef
Clinical features of gastric adenoma detected within 3 years after negative screening endoscopy in Korea Hyun Young Kim Gastroenterology Report.2022;[Epub] CrossRef
The push for high quality care in all fields of medicine highlights the importance of establishing and adhering to quality indicators.In response, several gastrointestinal societies have established quality indicators specific to Barrett’s esophagus, which serve to createthresholds for performance while standardizing practice and guiding value-based care. Recent studies, however, have consistentlydemonstrated the lack of adherence to these quality indicators, particularly in surveillance (appropriate utilization of endoscopy andobtaining biopsies using the Seattle protocol) and endoscopic eradication therapy practices. These findings suggest that innovativeinterventions are needed to address these shortcomings in order to deliver high quality care to patients with Barrett’s esophagus.
Citations
Citations to this article as recorded by
Endoskopische Diagnostik und Therapie des Ösophaguskarzinoms Alanna Ebigbo, Andreas Probst, Helmut Messmann Die Onkologie.2025;[Epub] CrossRef
Measuring and improving quality in esophageal care and swallowing disorders Alexander T Reddy, Joshua P Lee, David A Leiman Diseases of the Esophagus.2024;[Epub] CrossRef
Impact of Residing in Below Median Household Income Districts on Outcomes in Patients with Advanced Barrett’s Esophagus Suqing Li, Yusuke Fujiyoshi, Sechiv Jugnundan, Gary May, Norman Marcon, Jeffrey Mosko, Christopher Teshima Journal of the Canadian Association of Gastroenterology.2023; 6(4): 137. CrossRef
Clinical variation in surveillance and management of Barrett’s esophagus: A cross-sectional study of gastroenterologists and gastrointestinal surgeons Jamielyn DC Cruz, David Paculdo, Divya Ganesan, Meredith Baker, Rebecca J Critchley-Thorne, Nicholas J Shaheen, Sachin Wani, John W Peabody Medicine.2022; 101(51): e32187. CrossRef
Risk Factors for Self-Expandable Metal Stent Complications in the Treatment of Esophageal Cancer: A Scoping Review Connor K. Wilson, Sara R. Frankowski, Susan C. Steelman, Issam Makhoul SN Comprehensive Clinical Medicine.2020; 2(8): 1163. CrossRef